Stockreport

Press Release: Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D patients Teizeild represents a potential signif [Read more]